Canadian study says oral medicine effective in treating COVID-19

Latest News

Canadian study says oral medicine effective in treating COVID-19

Saturday, January 23, 2021

Print this page Email A Friend!

MONTREAL,Canada(AFP) — A major clinical trial shows that an inflammatory drug called colchicine is effective in treating COVID-19 and reduces the risk of complications from the disease, doctors in Canada said.

The results of thestudyare a "major scientific discovery" and make colchicine — a medicine used to treat gout — "the world's first oral drug that could be used to treat non-hospitalised patients with COVID-19," the Montreal Heart Institute said in a statement late Friday.

Thestudyresults show that colchicine reduced by 21 per cent the risk of death or hospitalisations in patients with COVID-19 compared to placebo, the institute said.

Thestudywas carried out in Canada, the US, Europe and South America among a population of 4,488 patients.

In 4,159 of these patients, in whom the diagnosis of COVID-19 was proven by a naso-pharyngeal PCR test, use of colchicine reduced hospitalisations by 25 per cent, the need for mechanical ventilation by 50 per cent, and deaths by 44 per cent, thestudyconcluded.

Colchicine is effective in preventing dangerous inflammatory syndromes called "cytokine storms" and reducing complications associated with COVID-19, said Dr Jean-Claude Tardif, director of the MHI Research Center and principal investigator in thisstudy.

"We are pleased to offer the first oral medication in the world whose use could have a significant impact on public health and potentially prevent COVID-19 complications for millions of patients," Tardif said.

Thestudywas conducted among COVID-19 patients not hospitalised at the time of enrolment in the trial, and withat least one risk factor for COVID-19 complications.

"This is the world's largeststudytesting an orally administered drug in non-hospitalised patients with COVID-19," the heart institute said.

Now you can read the Jamaica Observer ePaper anytime, anywhere. The Jamaica Observer ePaper is available to you at home or at work, and is the same edition as the printed copy available at




1. We welcome reader comments on the top stories of the day. Some comments may be republished on the website or in the newspaper � email addresses will not be published.

2. Please understand that comments are moderated and it is not always possible to publish all that have been submitted. We will, however, try to publish comments that are representative of all received.

3. We ask that comments are civil and free of libellous or hateful material. Also please stick to the topic under discussion.

4. Please do not write in block capitals since this makes your comment hard to read.

5. Please don't use the comments to advertise. However, our advertising department can be more than accommodating if emailed:

6. If readers wish to report offensive comments, suggest a correction or share a story then please email:

7. Lastly, read our Terms and Conditions and Privacy Policy

comments powered by Disqus



Today's Cartoon

Click image to view full size editorial cartoon